Implementation of the FINDRISC screening tool via eHealth across 19 Latin American and Caribbean countries identified that 35% of the 47,267 participants were at high risk for type 2 diabetes.
Cross-Sectional (n=47,267)
Yes
Large-scale digital screening using the FINDRISC tool in Latin America and the Caribbean identified that approximately 35% of the screened population is at high risk for developing type 2 diabetes.
Background: The prevalence of type 2 diabetes (T2D) continues to increase in the Americas. Identifying people at risk for T2D is critical to the prevention of T2D complications, especially cardiovascular disease. This study gauges the ability to implement large population-based organized screening campaigns in 19 Latin American and Caribbean countries to detect people at risk for T2D using the Finnish Diabetes Risk Score (FINDRISC). Methods: eHealth during a Guinness World Record attempt campaign between October 25 and November 1, 2021. FINDRISC is a non-invasive screening tool based on age, body mass index, waist circumference, physical activity, daily intake of fruits and vegetables, history of hyperglycemia, history of antihypertensive drug treatment, and family history of T2D, assigning a score ranging from 0 to 26 points. A cut-off point of ≥ 12 points was considered as high risk for T2D. Results: The final sample size consisted of 29,662 women (63%) and 17,605 men (27%). In total, 35% of subjects were at risk of T2D. The highest frequency rates (FINDRISC ≥ 12) were observed in Chile (39%), Central America (36.4%), and Peru (36.1%). Chile also had the highest proportion of people having a FINDRISC ≥15 points (25%), whereas the lowest was observed in Colombia (11.3%). Conclusions: eHealth technology over social networks in Latin American and Caribbean populations to detect people with high risk for T2D. Primary healthcare strategies are needed to perform T2D organized screening to deliver early, accessible, culturally sensitive, and sustainable interventions to prevent sequelae of T2D, and reduce the clinical and economic burden of cardiometabolic-based chronic disease.
Nieto‐Martínez et al. (Mon,) conducted a cross-sectional in Risk for Type 2 Diabetes (n=47,267). FINDRISC (Finnish Diabetes Risk Score) screening via eHealth was evaluated on High risk for Type 2 Diabetes (FINDRISC score ≥ 12 points) (95% CI 34.3-35.2). Implementation of the FINDRISC screening tool via eHealth across 19 Latin American and Caribbean countries identified that 35% of the 47,267 participants were at high risk for type 2 diabetes.